AstraZeneca Gets in on ADC Therapeutics' Mega $200M Funding Round Post author:Sam Post published:October 22, 2017 Post category:BioPharma ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace You Might Also Like Former Google Exec Steps Down as GRAIL CEO August 2, 2017 GlycoMimetics Stock Takes Off on Positive Phase II Leukemia Data, Breakthrough Tag May 17, 2017 Adicet Bio Appoints Chief Medical Officer June 27, 2017